Australia markets open in 5 hours 2 minutes

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0386+0.0286 (+2.83%)
At close: 03:52PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.0100
Open1.0599
Bid0.9696 x 3000
Ask1.0500 x 1000
Day's range1.0400 - 1.0400
52-week range0.9100 - 7.4000
Volume29
Avg. volume55,373
Market cap10.715M
Beta (5Y monthly)1.34
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Nephros Announces Results for Quarter Ended September 30, 2022

    Third-Quarter Net Revenue of $2.4 Million; Active Customer Sites Increase 18% YoY to a New Record Level SOUTH ORANGE, NJ, Nov. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2022. Financial HighlightsWater Filtration Business Segment Highlights* Net revenue from continuing operations of

  • GlobeNewswire

    Nephros Third Quarter 2022 Financial Results Conference Call

    SOUTH ORANGE, NJ, Oct. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November 2, 2022 after market close and will host a conference call that same day at 4:30 pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317

  • GlobeNewswire

    Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022

    Sale Reduces Cash Burn, Includes Seven-Year Earn-Out Provision;Third Quarter Revenue Expected to be Approximately $2.5 Million; Active Customer Sites Increase 18% YoY SOUTH ORANGE, NJ, Oct. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it has entered into a definitive agreement to sell its Pathogen Detection Systems (